Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-14

Clinical Trial Update: Effect of Magnesium on Remifentanil Induced Cough [Phase 4]

View source ↗

Summary

Phase 4 clinical trial examining whether magnesium reduces remifentanil-induced cough.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Magnesium (magnesium)
  • Remifentanil (remifentanil)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Cough | Phase 4 | Status: UNKNOWN